Furthermore, both GRB2 and MEK5/ERK5 are commonly overexpressed in breast cancer and associated with poor overall survival, and targeting of these proteins/pathways is shown to suppress breast cancer progression [41–43]. The gene discussed is MAP2K5; the disease is breast cancer.